Ativan: Clinical Trials

5 trials of Ativan, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 25Completed 5
Phase 32Completed 2

Follow Ativan: new trials by email Literature Review of Ativan trials Research Report on Ativan

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Therapies for Down Syndrome Regression Disorder
Lorazepam, Intravenous immunoglobulin (IVIG), Tofacitinib - Down Syndrome, Regression
Phase 2CompletedUniversity of Colorado, Denver662023-06-292026-09-03
Sunitinib or Cediranib for Alveolar Soft Part Sarcoma
Cediranib, Sunitinib, Prochlorperazine - Sarcoma, Alveolar Soft Part
Phase 2CompletedNational Cancer Institute (NCI)342011-07-182026-02-02
Efficacy and Safety Study Comparing Lorazepam and Diazepam for Children in the Emergency Department With Seizures (Status 2)
lorazepam or diazepam - Status Epilepticus
Phase 2 / Phase 3CompletedEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)2592008-02-012012-12-18
Effects of Pentazocine Versus Lorazepam on Manic Symptoms
Pentazocine, Lorazepam - Bipolar Disorder, Schizoaffective Disorder
Phase 2CompletedMclean Hospital192007-01-012019-03-06
Lorazepam Sedation for Critically Ill Children
Lorazepam, Midazolam, Lorazepam CI - Critical Illness
Phase 2 / Phase 3CompletedThe Emmes Company, LLC1792004-09-012023-03-20

Conditions studied

Autoimmune Diseases (1)  ·  Autoimmune Diseases of the Nervous System (1)  ·  Bipolar Disorder (1)  ·  Catatonia (1)  ·  Critical Illness (1)  ·  Down Syndrome (1)  ·  Mania (1)  ·  Psychotic Disorders (1)  ·  Sarcoma, Alveolar Soft Part (1)  ·  Status Epilepticus (1)

Sponsors

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)  ·  Mclean Hospital (1)  ·  National Cancer Institute (NCI) (1)  ·  The Emmes Company, LLC (1)  ·  University of Colorado, Denver (1)

Countries

United States (5)  ·  Canada (1)

Top investigators

Alice P Chen, M.D. (1)  ·  Beth L Murphy, MD/PhD (1)  ·  Elise Sannar, MD (1)  ·  James Chamberlain, MD (1)  ·  Jeffrey L Blumer, MD, PhD (1)  ·  Joaquin Espinosa, PhD (1)  ·  Jonathon Santoro, MD (1)

Results publications

PMID 24756515, PMID 27993298, PMID 36302173